Earnings Summary

Amedisys Inc’s revenue jumped 6.91% since last year same period to $591.19Mn in the Q2 2024. On a quarterly growth basis, Amedisys Inc has generated 3.46% jump in its revenue since last 3-months.

Amedisys Inc’s net profit jumped 140.24% since last year same period to $32.3Mn in the Q2 2024. On a quarterly growth basis, Amedisys Inc has generated 124.31% jump in its net profits since last 3-months.

Amedisys Inc’s net profit margin jumped 137.64% since last year same period to 5.46% in the Q2 2024. On a quarterly growth basis, Amedisys Inc has generated 116.81% jump in its net profit margins since last 3-months.

Amedisys Inc’s price-to-earnings ratio after this Q2 2024 earnings stands at 34.69.

Amedisys Inc’s earning per share (EPS) estimates for the current quarter stand at 1.17 - a -1.68% fall from last quarter’s estimates.

Amedisys Inc’s earning per share (EPS) estimates for the current year stand at 1.17.

Amedisys Inc’s earning per share (EPS) fell -3.65% since last year same period to 1.32 in the Q2 2024. This indicates that the Amedisys Inc has generated -3.65% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Amedisys Inc’s return on assets (ROA) stands at 0.06.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Amedisys Inc’s return on equity (ROE) stands at 0.08.